drugset / Trial / NCT05882812

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis

NCT05882812

Phase 2 Completed 200 enrolled ZetrOZ, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the ability of long-duration low-intensity therapeutic ultrasound (LITUS) to alleviate knee Osteoarthritis pain over an 8-week period. The primary objective of this study is to evaluate the analgesic effect of LITUS in subjects suffering from knee Osteoarthritis pain. Secondary objectives are to assess the ability of LITUS to improve joint function.

Timeline

Start
2023-06-03
Primary completion
2023-12-31
Completion
2024-02-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 2.5 % Topical

Indications